Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
Jia-Zhou Ye, Jun-Ze Chen, Zi-Hui Li, Tao Bai, Jie Chen, Shao-Liang Zhu, Le-Qun Li, Fei-Xiang Wu
Jia-Zhou Ye, Zi-Hui Li, Tao Bai, Jie Chen, Shao-Liang Zhu, Le-Qun Li, Fei-Xiang Wu, Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Jia-Zhou Ye, Tao Bai, Jie Chen, Shao-Liang Zhu, Le-Qun Li, Fei-Xiang Wu, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Jia-Zhou Ye, Tao Bai, Jie Chen, Shao-Liang Zhu, Le-Qun Li, Fei-Xiang Wu, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Jun-Ze Chen, Department of General Surgery, The Ninth Affiliated Hospital of Guangxi Medical University, Beihai 536000, Guangxi Zhuang Autonomous Region, China
Author contributions: Ye JZ and Chen JZ equally contributed to this work; Ye JZ, Li LQ and Wu FX designed the research; Ye JZ, Chen JZ, Bai T, Chen J, Zhu SL, Li LQ, and Wu FX performed the research; Ye JZ, Chen JZ, and Li ZH analyzed the data; Ye JZ and Chen JZ wrote the paper.
Supported by Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, No. GKZ201604; Key Project of Guangxi Health and Family Planning Commission, China, No. S201513; and Key Project of Guangxi Science and Technology Department, China, No. Gui Ke AB16380242.
Institutional review board statement: The study was reviewed and approved by the Clinical Research Ethics Committee of Affiliated Tumor Hospital of Guangxi Medical University.
Informed consent statement: Informed consent was not required from the patients for the study as the analysis used anonymous clinical data. Individuals cannot be identified based on the data presented.
Conflict-of-interest statement: The authors declare no conflicts of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Fei-Xiang Wu, MD, Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, No. 71, Hedi Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
wufeixiang@gxmu.edu.cn
Telephone: +86-771-5320971 Fax: +86-771-5320971
Received: July 26, 2017
Peer-review started: July 26, 2017
First decision: August 10, 2017
Revised: September 9, 2017
Accepted: September 20, 2017
Article in press: September 19, 2017
Published online: November 7, 2017
Processing time: 103 Days and 11.9 Hours
